Skip to Content

Polynovo Ltd CALZF

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Polynovo Ltd develops innovative medical devices for a number of medical applications, utilizing the patented biodegradable polymer technology NovoSorb. NovoSorb is a family of proprietary medical-grade polymers that can be utilized to manufacture novel medical devices designed to support tissue repair and which then degrade in a defined fashion in-situ to harmless by-products. The company earns a maximum from the United States of America.

Contact
Unit 2, 320 Lorimer Street
Port Melbourne, VIC, 3207, Australia
T +61 386814050
Sector Healthcare
Industry Biotechnology
Most Recent Earnings
Fiscal Year End Jun 30, 2021
Stock Type Classic Growth
Employees 8